| Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Revenues | ||||||
Sales of goods | ||||||
386 | 377 | 298 | 224 | 0 | 0 | 0 |
Total revenues | ||||||
386 | 377 | 298 | 224 | 0 | 0 | 0 |
Operating expenses | ||||||
Research and development | ||||||
7,620 | 8,119 | 8,155 | 7,874 | 0 | 0 | 0 |
General and administrative | ||||||
0 | 0 | - | - | 0 | 0 | - |
Marketing | ||||||
5,096 | 5,096 | 5,103 | 5,428 | 0 | 0 | 0 |
Cost of sales | ||||||
152 | 160 | 163 | 149 | 0 | 0 | 0 |
Total expenses | ||||||
11,583 | 13,331 | 13,429 | 13,459 | 0 | 0 | 0 |
Loss from operations | ||||||
-11,197 | -12,954 | -13,131 | -13,235 | 0 | 0 | 0 |
Net finance income (costs) | ||||||
-383 | -349 | -240 | -194 | 0 | 0 | 0 |
Loss attributable to the equity holders | ||||||
-11,352 | -13,143 | -13,429 | -13,429 | 0 | 0 | 0 |
Income tax provision (recovery) | ||||||
- | - | 0 | - | - | - | 0 |
Net loss | ||||||
- | - | 0 | - | - | - | 0 |
Net income (loss) per share Basic & Diluted | ||||||
-0.05 | -0.04 | -0.05 | -0.06 | -0.09 | -0.05 | -0.06 |
Weighted average number of common shares outstanding Basic & Diluted | ||||||
61,519 | 59 | 57 | -53,191 | 53,301 | 51 | 49 |